Page 3 - John Beigel News Today

MONDAY, June 27, 2022 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel will vote on Tuesday whether to recommend that updated COVID-19 booster shots be used this

Moderna says trial results suggest redesigned vaccines can better protect against variants

Dr. Anthony Fauci and top officials at the agency he heads scrambled in April 2020 to answer questions about altering the endpoint in a trial testing the antiviral drug called remdesivir, newly obtained emails show. Nothing new – more indirect (or direct) evidence exposing their true criminal activities! Telegram Chanel Here:| USSA News

Dr. Anthony Fauci and top officials at the agency he heads scrambled in April 2020 to answer questions ...

A federal advisory committee of outside experts grappled Wednesday with how to fashion the U.S. coronavirus vaccine strategy for the rest of the year, amid growing evidence that new variants have eroded some of the power of the existing vaccines.

Gilead Sciences Inc. is recalling 55,000 vials of the COVID-19 drug remdesivir in the US after after a complaint about glass particles was confirmed by a company investigation.

WASHINGTON - Millions more people in the United States will soon be able to receive an extra dose of any coronavirus vaccine, regardless of their initial vaccination - a flexibility that comes along with the authorization Wednesday of the Moderna and Johnson & Johnson booster shots by federal regulators.

But before more people roll up their sleeves, the U.S. CDC will consult experts this week before finalizing official recommendations for who should get boosters and when.

New CDC data suggests the single-shot vaccine has the highest rate of breakthrough infections.

New research shows that there were few safety issues when mixing and matching vaccines for booster doses, and the immune responses appear to be more potent.